Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT02629692
Title	Safety and Anti-leukemic Activity of Vodobatinib (K0706) for Treatment of Ph+ CML Resistant/Intolerant to >=3 Prior CML Therapies
Recruitment	Active, not recruiting
Gender	both
Phase	Phase Ib/II
Variant Requirements	Yes
Sponsors	Sun Pharma Advanced Research Company Limited
Indications	acute lymphoblastic leukemia chronic myeloid leukemia
Therapies	K0706
Age Groups:	adult \| senior
Covered Countries	USA \| TUR \| ROU \| ITA \| HUN \| GBR \| FRA \| ESP \| BEL